Rachel Jones

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

Chetan Mukhtyar, R Lee, Denise Scott Brown et al. · Annals of the Rheumatic Diseases · 2008 · 1.2K citations

Medicine, Cancer Biology, Oncology +14

Long‐term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re‐treatment

Kenneth G. C. Smith, Rachel Jones, Stella Burns et al. · Arthritis & Rheumatism · 2006 · 400 citations

Life Sciences, Immunology, Pharmacotherapy +17

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis

Rachel Jones, Alastair Ferraro, Afzal Chaudhry et al. · Arthritis & Rheumatism · 2009 · 355 citations

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Darren M. Roberts, Rachel Jones, Rona Smith et al. · Journal of Autoimmunity · 2014 · 298 citations

Life Sciences, Hematology, Immunology +13